Trivium Point Advisory LLC Cuts Holdings in Aflac Incorporated $AFL

Trivium Point Advisory LLC decreased its holdings in Aflac Incorporated (NYSE:AFL) by 29.1% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,968 shares of the financial services provider’s stock after selling 808 shares during the period. Trivium Point Advisory LLC’s holdings in Aflac were worth $208,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Invesco LLC boosted its position in Aflac by 3.9% during the 2nd quarter. Invesco LLC now owns 34,577 shares of the financial services provider’s stock valued at $3,646,000 after acquiring an additional 1,287 shares in the last quarter. GC Wealth Management RIA LLC bought a new stake in Aflac during the 2nd quarter valued at $995,000. Sound Income Strategies LLC boosted its position in Aflac by 9.5% during the 2nd quarter. Sound Income Strategies LLC now owns 3,667 shares of the financial services provider’s stock valued at $387,000 after acquiring an additional 319 shares in the last quarter. City Holding Co. boosted its position in Aflac by 5.5% during the 2nd quarter. City Holding Co. now owns 56,347 shares of the financial services provider’s stock valued at $5,942,000 after acquiring an additional 2,926 shares in the last quarter. Finally, Beacon Capital Management LLC boosted its position in Aflac by 3.3% during the 2nd quarter. Beacon Capital Management LLC now owns 4,700 shares of the financial services provider’s stock valued at $496,000 after acquiring an additional 151 shares in the last quarter. Institutional investors own 67.44% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on the company. UBS Group dropped their target price on Aflac from $114.00 to $111.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 6th. Barclays set a $98.00 target price on shares of Aflac and gave the company an “underweight” rating in a research report on Monday, July 7th. Wells Fargo & Company increased their target price on shares of Aflac from $105.00 to $107.00 and gave the company an “equal weight” rating in a research report on Monday, August 11th. JPMorgan Chase & Co. increased their target price on shares of Aflac from $96.00 to $100.00 and gave the company a “neutral” rating in a research report on Tuesday, July 8th. Finally, Morgan Stanley increased their target price on shares of Aflac from $108.00 to $113.00 and gave the company an “equal weight” rating in a research report on Monday, August 18th. Three analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Aflac has an average rating of “Hold” and an average price target of $109.15.

Insider Buying and Selling at Aflac

In other news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction on Friday, August 8th. The shares were sold at an average price of $102.57, for a total value of $102,570.00. Following the sale, the director owned 25,105 shares in the company, valued at $2,575,019.85. This represents a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.90% of the stock is owned by insiders.

Aflac Trading Down 0.8%

NYSE AFL opened at $110.81 on Thursday. The company has a fifty day simple moving average of $105.97 and a two-hundred day simple moving average of $105.36. The stock has a market cap of $59.26 billion, a P/E ratio of 25.13, a P/E/G ratio of 3.12 and a beta of 0.86. Aflac Incorporated has a 12-month low of $96.95 and a 12-month high of $115.50. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.33.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Tuesday, August 5th. The financial services provider reported $1.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.07. The business had revenue of $4.16 billion during the quarter, compared to analysts’ expectations of $4.30 billion. Aflac had a net margin of 15.32% and a return on equity of 15.08%. The business’s quarterly revenue was down 19.0% on a year-over-year basis. During the same quarter last year, the company posted $1.83 earnings per share. On average, analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 2nd. Stockholders of record on Wednesday, August 20th were paid a $0.58 dividend. The ex-dividend date was Wednesday, August 20th. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.1%. Aflac’s dividend payout ratio is presently 52.61%.

Aflac announced that its board has authorized a share buyback program on Tuesday, August 12th that allows the company to repurchase 100,000,000 outstanding shares. This repurchase authorization allows the financial services provider to reacquire shares of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.